期刊文献+

晚期鼻咽癌调强放疗中内耳道受量评价 被引量:7

Radiation dose to the internal auditory canal in advanced nasopharyngeal carcinoma treated with intensity- modulated radiation therapy
暂未订购
导出
摘要 目的:回顾性评价晚期鼻咽癌调强放疗中双侧内耳道(internal auditory canal,IAC)的受量情况。方法:选择已完成调强放射治疗的13例鼻咽癌患者,所有患者均有明确病理诊断且均接受33次调强放疗。再由一名主治医师在原始的CT图像上勾画出双侧的内耳道,最后通过DVH图对双侧的内耳道受量进行分析,包括双侧内耳道的最大剂量(D_(max))、最小剂量(D_(min))及平均剂量(D_(mean))。结果:左侧内耳道的最大剂量(D_(max))、最小剂量(D_(min))及平均剂量(D_(mean))的均值分别为5 207.4c Gy、4 306.0c Gy、4 724.0c Gy;右侧内耳道的最大剂量(D_(max))、最小剂量(D_(min))及平均剂量(D_(mean))的均值分别为5 737.9c Gy、4 581.7c Gy、5 261.9c Gy。结论:晚期鼻咽癌的调强放疗中,在不牺牲肿瘤靶区的前提下建议进行内耳道勾画并限制其接受过高照射剂量。 Objective: To retrospectively evaluate the dose to the internal auditory canal( IAC) in patients with advanced nasopharyngeal carcinoma treated with intensity- modulated radiotherapy. Methods: Chose thirteen advanced nasopharyngeal carcinoma patients who have completed the intensity- modulated radiotherapy of 33 fractions. Then a attending physician contoured the IAC in the original CT images. Finally,we analysed the dose volume histogram( DVH) of the left and right IAC including the maximum dose( Dmax),minimum dose( Dmin) and the average dose( Dmean). Results: The mean of maximum dose of the left IAC( Dmax),minimum dose( Dmin) and the average dose( Dmean) were respectively 5 207. 4c Gy,4 306. 0 c Gy,4 724. 0 c Gy,and the right was 5 737. 9c Gy,4 581. 7c Gy,5 261. 9c Gy respectively. Conclusion: We suggest delineate and constrain the dose of IAC without sacrifice the tumor target region of the advanced nasopharyngeal carcinoma treated with intensity- modulated radiotherapy.
出处 《现代肿瘤医学》 CAS 2016年第5期809-812,共4页 Journal of Modern Oncology
关键词 内耳道 鼻咽癌 调强放疗 internal auditory canal nasopharyngeal carcinoma intensity-modulated radiotherapy
  • 相关文献

参考文献14

  • 1Heming Lu,Luxing Peng,Xianbin Yuan,Yanrong Hao,Zhiping Lu,Jiaxin Chen,Jinjian Cheng,Shan Deng,Junzhao Gu,Qiang Pang,Jian Qin.??Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: A treatment paradigm also applicable to patients in Southeast Asia(J)Cancer Treatment Reviews . 2009 (4)
  • 2Sager O,Beyzadeoglu M,Dincoglan F,et al.Management of vestibular schwannomas with linear accelerator-based stereotactic radiosurgery:A single center experience. TUMORI . 2013
  • 3Low WK,Toh ST,Wee J,et al.Sensori-hearing loss after chemotherapy and radiochemotherapy. Journal of Clinical Oncology . 2006
  • 4Janjira Petsuksiri,Achariyaporn Sermsree,Kullathorn Thephamongkhol,Phawin Keskool,Kanthong Thongyai,Yaowalak Chansilpa,Pittayapoom Pattaranutaporn.Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients. Radiation Oncology . 2011
  • 5Wang Ling-Feng,Kuo Wen-Rei,Ho Kuen-Yao,Lee Ka-Wo,Lin Chih-Shin.A long-term study on hearing status in patients with nasopharyngeal carcinoma after radiotherapy. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology . 2004
  • 6Yilmaz Yavuz Fuat,Aytas F Ilknur,Akdogan Ozgur,Sari Kamran,Savas Zuleyha Gorgu,Titiz Ali,Tumoz Mubeccel,Unal Adnan.Sensorineural hearing loss after radiotherapy for head and neck tumors: a prospective study of the effect of radiation. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology . 2008
  • 7Pacholke Heather D,Amdur Robert J,Schmalfuss Ilona M,Louis Debbie,Mendenhall William M.Contouring the middle and inner ear on radiotherapy planning scans. American journal of clinical oncology . 2005
  • 8Soo K-C,Tan E-H,Wee J,Lim D,Tai B-C,Khoo M-L,Goh C,Leong S-S,Tan T,Fong K-W,Lu P,See A,Machin D.Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. British Journal of Cancer . 2005
  • 9Hellberg Victoria,Wallin Inger,Eriksson Sofi,Hernlund Emma,Jerremalm Elin,Berndtsson Maria,Eksborg Staffan,Arnér Elias S J,Shoshan Maria,Ehrsson Hans,Laurell G?ran.Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity. Journal of the National Cancer Institute . 2009
  • 10Posner Marshall R,Hershock Diane M,Blajman Cesar R,Mickiewicz Elizabeth,Winquist Eric,Gorbounova Vera,Tjulandin Sergei,Shin Dong M,Cullen Kevin,Ervin Thomas J,Murphy Barbara A,Raez Luis E,Cohen Roger B,Spaulding Monica,Tishler Roy B,Roth Be.Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. The New England Quarterly . 2007

同被引文献29

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部